The Fourth Affiliated Hospital Of Zhejiang University School Of Medicine
Clinical trials sponsored by The Fourth Affiliated Hospital Of Zhejiang University School Of Medicine, explained in plain language.
-
New combo drug study aims to boost weight loss results
Disease control Not yet recruitingThis study tests whether taking two weight-loss drugs together works better than one alone. Overweight or obese adults will receive either liraglutide or liraglutide plus orlistat for 24 weeks. The goal is to see which approach leads to more weight loss.
Phase: PHASE4 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:55 UTC
-
New position therapy could save ARDS Patients' lungs
Disease control Not yet recruitingThis study tests if lying on your side at different angles (30°, 90°, 120°) can improve lung function in people with acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers will use a special imaging tool to monitor lung activity in real time. The goal i…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:53 UTC
-
Ancient herb may protect kidneys during surgery
Disease control Not yet recruitingThis study tests a traditional Chinese medicine called Shenkangling for people who have kidney injury after surgery. The goal is to see if it can help the kidneys recover and work better. About 100 adults aged 18 to 65 who need kidney surgery will take part. The medicine is given…
Phase: PHASE4 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
New drug cocktail targets advanced colon cancer
Disease control Not yet recruitingThis study tests a combination of four drugs (irinotecan liposome, capecitabine, bevacizumab, and camrelizumab) as a second or later treatment for people with metastatic colorectal cancer that has spread. The goal is to see if this mix can slow or stop cancer growth. The trial pl…
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:45 UTC
-
App-Based rehab aims to boost heart recovery in young patients
Disease control Not yet recruitingThis study tests a new smartphone-based program to help young and middle-aged adults recover after a heart attack. The program uses an app to guide exercise, diet, medication, and mental health, with support from a team of doctors, nurses, and therapists. Researchers will check i…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 03:43 UTC
-
Can a herbal injection protect hearts during sepsis? new trial aims to find out
Disease control Not yet recruitingThis study tests whether Danhong injection, a traditional Chinese medicine, can protect the heart in people with sepsis. Researchers will give the injection or a placebo to 140 patients with sepsis-related heart injury and measure heart function over 7 days, plus survival at 28 d…
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug combo targets tough lung cancer that spread to liver
Disease control Not yet recruitingThis study tests whether combining two drugs, SKB264 and anlotinib, can shrink tumors or slow disease in people with advanced non-small cell lung cancer that has spread to the liver and no longer responds to EGFR-targeted therapy. About 27 adults will receive the combination and …
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
New drug combo aims to tackle diabetes and fatty liver together
Disease control Not yet recruitingThis study is testing whether adding a third diabetes drug (alogliptin) to a standard two-drug combination (pioglitazone and metformin) works better for people who have both type 2 diabetes and fatty liver disease. Researchers will enroll 80 participants to see if the three-drug …
Phase: PHASE4 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
New nursing approach aims to boost recovery after knee replacement
Symptom relief Not yet recruitingThis study tests a nursing program based on the ABC-X model for 117 adults aged 30-65 having their first total knee replacement. The program focuses on managing stress, building coping skills, and involving family support. Researchers will measure psychological resilience, self-c…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated May 17, 2026 03:45 UTC
-
Could a bacterial extract tame stubborn hives?
Symptom relief Not yet recruitingThis study looks at whether adding a bacterial lysate (OM-85) to standard antihistamines can better control chronic spontaneous urticaria (CSU), a condition causing long-term hives and itching. About 132 adults aged 18-65 with antihistamine-resistant CSU will be observed over 12 …
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated May 17, 2026 03:42 UTC
-
New study aims to break social media addiction by fighting 'Rest Shame'
Symptom relief Not yet recruitingThis study will test a program based on cognitive behavioral therapy (CBT) to help university students who feel guilty about resting (called 'rest shame') reduce their social media addiction. About 120 students aged 18-25 who experience rest shame will participate. The goal is to…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated May 17, 2026 03:42 UTC
-
AI chatbot tested to lift mood in stroke survivors
Symptom relief Not yet recruitingThis study looks at whether a chatbot on Doubao software can help people who feel depressed after a stroke. About 240 participants will use the chatbot to get positive psychological support. The goal is to see if it reduces depression symptoms and improves quality of life. This i…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New app aims to boost knee surgery recovery at home
Symptom relief Not yet recruitingThis study tests whether a smartphone app can improve recovery for 60 adults after knee ligament surgery. The app provides exercise videos, lets patients upload their own exercise videos for feedback, and offers online consultations with nurses and therapists. The goal is to see …
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated May 06, 2026 16:15 UTC
-
Belly button therapy for IBS? scientists probe gut microbes for answers
Knowledge-focused Not yet recruitingThis study looks at how a traditional therapy called umbilical moxibustion (applying heat to the belly button) might help people with irritable bowel syndrome (IBS). Researchers will compare gut bacteria and small molecules in 60 adults who receive the therapy versus those who do…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 03:45 UTC
-
Brain scans reveal how sensory training rewires chronic back pain
Knowledge-focused Not yet recruitingThis study looks at how a type of sensory training changes brain connections in people with long-term low back pain. Researchers will use MRI scans to track brain changes before and after training, along with pain and function scores. The goal is to understand how the brain adapt…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 03:43 UTC
-
New app aims to help lung disease patients manage care at home
Knowledge-focused Not yet recruitingThis study will interview patients with interstitial lung disease to understand what health information they need at home. Researchers will then create a WeChat mini-program to deliver education, manage follow-ups, and share test results. The goal is to improve quality of life an…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Ancient wisdom meets AI: new system aims to tackle Three-Headed chronic disease monster
Knowledge-focused Not yet recruitingThis study aims to create an AI system that combines Traditional Chinese Medicine (TCM) body types with modern data to give personalized health advice. Researchers will enroll 195 adults who have all three conditions: high blood pressure, high blood sugar, and high cholesterol. T…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC